John Feore serves as the Director of Health Policy and Advocacy for the Institute for Gene Therapies (IGT), a non-profit advocacy organization launched in 2020 to help address coverage, access, and reimbursement challenges surrounding gene therapies.
Prior to joining IGT, Mr. Feore was an Associate Principal in Avalere’s Center for Healthcare Transformation. During his time at Avalere, Mr. Feore focused on public policy issues related to prescription drug coverage and reimbursement and the value-based transformation of the US health care system. He worked closely with life sciences companies, providers, suppliers, and trade associations on issues related to Medicare and Medicaid, federal health policy, and drug pricing and reimbursement among others.